South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and ...
If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIFICO ...
GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million ...
Andelyn Biosciences and PQP Group have partnered to streamline cell and gene therapy supply to the EU and UK, integrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results